GENEXPRESS INFORMATICS, INC.

Basic Information

13170G Pond Springs Road
Suite 5
Austin, TX, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 807519264
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2


  1. Development of biological based nanoparticles for improved smoke/obscurant formulations

    Amount: $95,027.00

    Studies have shown the potential health and environmental hazards associated with hexachloroethane (HC) and terephthalic (TA) smoke/obscurants. In order to avoid using these materials, new chemical fo ...

    STTR Phase I 2012 Army Department of Defense
  2. Development of Biological Obscurants

    Amount: $751,177.00

    In Phase I, GeneXpress Informatics (GXI) and Dr. James P. Chambers of the University of Texas at San Antonio proposed to develop biological obscurants for battlefield applications based on the use of ...

    SBIR Phase II 2009 Navy Department of Defense
  3. Development of Biological Obscurants

    Amount: $69,998.00

    The DoD has funded a number of nanotechnology based obscurant projects. Recent studies have shown the potential health and environmental risk associated with nanoparticle exposures. Development of b ...

    SBIR Phase I 2007 Navy Department of Defense
  4. Compact Transcranial Doppler (TCD) for Bioastronautics Research

    Amount: $594,571.00

    Returning men to the Moon and manned Mars missions will require advanced bioastronanutics research. One possible risk is Decompression Sickness (DCS) resulting from extravehicular activity (EVA), aft ...

    SBIR Phase II 2006 National Aeronautics and Space Administration
  5. Multi-analyte Immuno-Magnetic Assay System (MIMAS)

    Amount: $747,163.00

    GeneXpress Informatics, Ten X Technology and the University of Texas Health Science Center at San Antonio (UTHSC-SA) has developed and demonstrated a Multi-ImmunoMagnetic Assay System (MIMAS) with a d ...

    SBIR Phase II 2006 Air Force Department of Defense
  6. Non-Invasive Transcranial Doppler Sonogram Device for Detection of Embolic Air in Cerebral Arteries

    Amount: $69,987.00

    Technology is needed to provide real-time assessment and evaluation of hematological parameters during prolong space flights and planetary missions. A key hematological parameter is the monitoring an ...

    SBIR Phase I 2005 National Aeronautics and Space Administration
  7. Multi-IMmmunotoxicity Assay System (MIMAS)

    Amount: $99,938.00

    GeneXpress Informatics, Inc. (GXI) proposes to develop a Multi-IMmunotoxicity Assay System (MIMAS) based upon the Luminex Corporation (Austin, TX) xMAP system, a flexible analyzer based on the princip ...

    SBIR Phase I 2005 Air Force Department of Defense
  8. Preferential Display (PD) based PROTECT system

    Amount: $749,698.00

    During the Phase I, GeneXpress Informatics (GXI) provided proof-of-concept for the Preferential Display (PD) technology. GXI's Preferential Display (PD) technology is a paradigm shift in high throughp ...

    SBIR Phase II 2004 Air Force Department of Defense
  9. Discovering Stress Related Gene Transcript for Bioreactor Monitoring

    Amount: $69,971.00

    GeneXpress Informatics, Inc. (GXI) and Dr. James P. Chambers of the University of Texas at San Antonio propose to use GXI's patent pending, Preferential Display (PD) technology to identify and isolate ...

    SBIR Phase I 2003 National Aeronautics and Space Administration
  10. Preferential Display (PD) based PROTECT system

    Amount: $99,998.00

    Exposure of humans to chemical or biological warfare agents has been demonstrate to be detected within hours of contact by measuring gene expression levels (profiles) on a genomic scale using microarr ...

    SBIR Phase I 2003 Air Force Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government